Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Clear-cell metastatic renal cell carcinoma × Sunitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 16 Gastrointestinal Stromal Tumors 7 Neoplasms 4 Multiple Myeloma 3 Kidney Neoplasms 3 Urologic Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Kidney Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thoracic Neoplasms 1 Somatostatinoma 1 Solid Tumors Refractory to Standard Therapy 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1 Pelvic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Nervous System Neoplasms 1

Interventions

Nivolumab 6 cabozantinib 5 Specimen Handling 5 pembrolizumab 4 Ipilimumab 4 CTLA-4 Antigen 4 Magnetic Resonance Spectroscopy 3 Biopsy 3 Blood Specimen Collection 2 Axitinib 2 tivozanib 1 sitravatinib 1 lenvatinib 1 fludarabine 1 belzutifan 1 aldesleukin 1 Zoledronic Acid 1 Tissue Banks 1 Selenomethionine 1 Radiotherapy 1 Nephrectomy 1 Metastasectomy 1 Inulin 1 Immunoglobulin G 1 Ibandronic Acid 1 Everolimus 1 Diphosphonates 1 Denosumab 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡